Predicting type 2 diabetes and testosterone effects in high-risk Australian men: development and external validation of a 2-year risk model.
Robledo KP, Marschner IC, Grossmann M, Handelsman DJ, Yeap BB, Allan CA, Foote C, Inder WJ, Stuckey BGA, Jesudason D, Bracken K, Keech AC, Jenkins AJ, Gebski V, Jardine M, Wittert G.
Robledo KP, et al. Among authors: wittert g.
Eur J Endocrinol. 2025 Jan 6;192(1):15-24. doi: 10.1093/ejendo/lvae166.
Eur J Endocrinol. 2025.
PMID: 39720906
Clinical Trial.